ClinVar Miner

Submissions for variant NM_006231.4(POLE):c.3407G>A (p.Arg1136Gln)

gnomAD frequency: 0.00002  dbSNP: rs761355093
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001575386 SCV000653205 uncertain significance not provided 2025-01-12 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1136 of the POLE protein (p.Arg1136Gln). This variant is present in population databases (rs761355093, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with POLE-related conditions. ClinVar contains an entry for this variant (Variation ID: 473594). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt POLE protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV001575386 SCV001802370 uncertain significance not provided 2021-04-01 criteria provided, single submitter clinical testing Not observed in large population cohorts (Lek 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Revvity Omics, Revvity RCV001575386 SCV004236431 uncertain significance not provided 2023-03-07 criteria provided, single submitter clinical testing
Ambry Genetics RCV004943995 SCV005478886 uncertain significance Hereditary cancer-predisposing syndrome 2024-12-10 criteria provided, single submitter clinical testing The p.R1136Q variant (also known as c.3407G>A), located in coding exon 28 of the POLE gene, results from a G to A substitution at nucleotide position 3407. The arginine at codon 1136 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.